TC Biopharm Ltd., of Edinburgh, Scotland, said it raised £1.18 million (US$1.82 million) in equity and grant funding to treat UK-based patients with melanoma, lung and kidney cancer. Scotland's only female angel group, Investing Women, led the £680,000 investment, with support from Scottish Investment Bank and WH Partnership.